SCM
ANIK icon

Stonepine Capital Management’s Anika Therapeutics ANIK Stock Holding History

Stonepine Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-190,590
Closed -$2.02M – 60
2025
Q2 		$2.02M Sell
190,590
-16,049
-8% -$203K 1.99% 15
2025
Q1 		$3.26M Sell
206,639
-31,583
-13% -$525K 3.17% 8
2024
Q4 		$3.92M Buy
238,222
+48,914
+26% +$965K 3.17% 9
2024
Q3 		$4.68M Buy
189,308
+23,911
+14% +$620K 2.95% 9
2024
Q2 		$4.19M Buy
165,397
+104,448
+171% +$2.71M 3.82% 7
2024
Q1 		$1.55M Buy
+60,949
New +$1.47M 1.23% 12

Other funds holding ANIK

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return